z-logo
open-access-imgOpen Access
INFUSION OF CYTOMEGALOVIRUS SPECIFIC CYTOTOXIC T LYMPHOCYTES FROM A SERO-NEGATIVE DONOR CAN FACILITATE RESOLUTION OF INFECTION AND IMMUNE RECONSTITUTION
Author(s) -
Biljana Horn,
Lei Bao,
Kimberly Dunham,
Mindy Stamer,
Stuart P. Adler,
Morton J. Cowan,
Kenneth G. Lucas
Publication year - 2008
Publication title -
the pediatric infectious disease journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 140
eISSN - 1532-0987
pISSN - 0891-3668
DOI - 10.1097/inf.0b013e318182026f
Subject(s) - viremia , medicine , ctl* , cytotoxic t cell , cytomegalovirus , immunology , virology , betaherpesvirinae , immune system , refractory (planetary science) , cytomegalovirus infection , human cytomegalovirus , stem cell , herpesviridae , viral disease , virus , biology , cd8 , in vitro , biochemistry , genetics , astrobiology
We report a stem cell transplant patient with a therapy-refractory cytomegalovirus (CMV) infection who received CMV-specific T cells from his sero-negative stem cell donor. This donor received the Towne strain CMV vaccine, and T cells were expanded using monocytes pulsed with pp65 overlapping peptides. CMV DNA decreased after the CTL infusion, and CMV-specific cytotoxicity increased. This strategy could be implemented in similar situations or with persistent viremia post-transplant.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom